<html>
<head>PUBMED IDs for B7-H6</head>
<body bgcolor='#C5F0F2'><h1>B7-H6</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19528259/'>The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.</a> July 30  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23801635/'>Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.</a> October 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24242703/'>B7-H6 protein expression has no prognostic significance in human gastric carcinoma.</a> October 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24242684/'>Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.</a> June 17  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24242679/'>Association of a genetic variant of CYP19A1 with multicentric development of lung adenocarcinomas.</a> November 14  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24242678/'>MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.</a> November 14  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24780758/'>Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.</a> October 14  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25877893/'>Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.</a> January 13  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26057798/'>Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.</a> March 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26891663/'>Knockdown of B7-H6 inhibits tumor progression and enhances chemosensitivity in B-cell non-Hodgkin lymphoma.</a> December 27  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28186488/'>Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation.</a> February 11  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28576831/'>Shifting the balance of activating and inhibitory natural killer receptor ligands on BRAF(V600E)melanoma lines with vemurafenib.</a> June 4  2017<br></body></html>
